GT Stevenson

414 total citations
10 papers, 336 citations indexed

About

GT Stevenson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, GT Stevenson has authored 10 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in GT Stevenson's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (4 papers) and CAR-T cell therapy research (3 papers). GT Stevenson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (4 papers) and CAR-T cell therapy research (3 papers). GT Stevenson collaborates with scholars based in United Kingdom and Germany. GT Stevenson's co-authors include TJ Hamblin, Freda K. Stevenson, M Wrightham, M J Glennie, Rebecca Cusack, Ten Feizi, Yashwant M. Deo, JG van de Winkel, JR Kalden and Thomas Valerius and has published in prestigious journals such as Blood.

In The Last Decade

GT Stevenson

9 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GT Stevenson United Kingdom	8	198	193	101	91	83	10	336
Christiane Charriaut France	7	219 1.1×	84 0.4×	40 0.4×	58 0.6×	103 1.2×	11	316
Robert Oldham United Kingdom	10	198 1.0×	223 1.2×	148 1.5×	42 0.5×	151 1.8×	15	423
Diane Razanajaona France	11	323 1.6×	91 0.5×	171 1.7×	36 0.4×	95 1.1×	15	486
Siska Wijngaarden Netherlands	7	185 0.9×	119 0.6×	73 0.7×	48 0.5×	37 0.4×	10	296
Hilma J. van der Horst Netherlands	7	115 0.6×	114 0.6×	81 0.8×	25 0.3×	131 1.6×	12	256
James W. Rohrer United States	14	327 1.7×	182 0.9×	192 1.9×	115 1.3×	104 1.3×	18	483
Carina Olsson Switzerland	8	294 1.5×	102 0.5×	169 1.7×	16 0.2×	71 0.9×	9	434
Maria-Concetta Verı́ United States	7	215 1.1×	178 0.9×	181 1.8×	12 0.1×	58 0.7×	9	371
Véronique Minard-Colin United States	5	308 1.6×	105 0.5×	59 0.6×	16 0.2×	156 1.9×	8	397
Michael Stanglmaier Germany	7	194 1.0×	177 0.9×	117 1.2×	75 0.8×	149 1.8×	9	418

Countries citing papers authored by GT Stevenson

Since Specialization

Citations

This map shows the geographic impact of GT Stevenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GT Stevenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GT Stevenson more than expected).

Fields of papers citing papers by GT Stevenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GT Stevenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GT Stevenson. The network helps show where GT Stevenson may publish in the future.

Co-authorship network of co-authors of GT Stevenson

This figure shows the co-authorship network connecting the top 25 collaborators of GT Stevenson. A scholar is included among the top collaborators of GT Stevenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GT Stevenson. GT Stevenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Valerius, Thomas, Roland Repp, George J. Weiner, et al.. (1996). HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood. 87(9). 3803–3812. 84 indexed citations

2.

Stevenson, Freda K., et al.. (1991). Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody. Blood. 77(5). 1071–1079. 71 indexed citations

3.

Stevenson, Freda K., et al.. (1991). Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody. Blood. 77(5). 1071–1079. 7 indexed citations

4.

Stevenson, Freda K., et al.. (1988). Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma. Blood. 72(6). 1985–1991. 18 indexed citations

5.

Wrightham, M, et al.. (1987). Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes. Blood. 69(3). 919–923. 7 indexed citations

6.

Hamblin, TJ, et al.. (1987). Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody. Blood. 69(3). 790–797. 39 indexed citations

7.

Stevenson, Freda K., M Wrightham, M J Glennie, et al.. (1986). Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 68(2). 430–436. 79 indexed citations

8.

Stevenson, Freda K., et al.. (1986). Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 68(2). 430–436. 13 indexed citations

9.

Hamblin, TJ, et al.. (1981). A human b-cell lymphoma synthesizing and expressing surface mu-chain in the absence of detectable light chain. Blood. 58(3). 552–556. 1 indexed citations

10.

Hamblin, TJ, et al.. (1981). A human b-cell lymphoma synthesizing and expressing surface mu-chain in the absence of detectable light chain. Blood. 58(3). 552–556. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact